NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi
NexImmune | 3: Initial statement of beneficial ownership of securities-Officer Marchio Albert N II
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
NexImmune | 3: Initial statement of beneficial ownership of securities-Officer STOVER TIMOTHY
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Verstandig Grant
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Gandhi Leena
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Yao Zhengbin
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director BARER SOL J
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director D'Angio Paul
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Bertram Timothy
NexImmune | SC 13D: Statement of acquisition of beneficial ownership by individuals-Sol J. Barer(9.17%)
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Gandhi Leena
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Verstandig Grant
NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer OELKE MATHIAS
NexImmune | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Trainer John
NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Yao Zhengbin
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director D'Angio Paul
No Data